These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 9176498)

  • 21. 4-1BB-mediated immunotherapy of rheumatoid arthritis.
    Seo SK; Choi JH; Kim YH; Kang WJ; Park HY; Suh JH; Choi BK; Vinay DS; Kwon BS
    Nat Med; 2004 Oct; 10(10):1088-94. PubMed ID: 15448685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer.
    Martinet O; Divino CM; Zang Y; Gan Y; Mandeli J; Thung S; Pan PY; Chen SH
    Gene Ther; 2002 Jun; 9(12):786-92. PubMed ID: 12040460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
    Dawicki W; Bertram EM; Sharpe AH; Watts TH
    J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
    Bertram EM; Lau P; Watts TH
    J Immunol; 2002 Apr; 168(8):3777-85. PubMed ID: 11937529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
    Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
    Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
    Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
    World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.
    Melero I; Johnston JV; Shufford WW; Mittler RS; Chen L
    Cell Immunol; 1998 Dec; 190(2):167-72. PubMed ID: 9878117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells.
    Kim J; Choi WS; La S; Suh JH; Kim BS; Cho HR; Kwon BS; Kwon B
    Blood; 2005 Mar; 105(5):2206-13. PubMed ID: 15522958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae.
    Wu ZQ; Khan AQ; Shen Y; Wolcott KM; Dawicki W; Watts TH; Mittler RS; Snapper CM
    Infect Immun; 2003 Jan; 71(1):196-204. PubMed ID: 12496166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
    Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
    J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis.
    Maerten P; Kwon BS; Shen C; De Hertogh G; Cadot P; Bullens DM; Overbergh L; Mathieu C; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
    Clin Exp Immunol; 2006 Feb; 143(2):228-36. PubMed ID: 16412046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of 4-1BB in immune responses.
    Vinay DS; Kwon BS
    Semin Immunol; 1998 Dec; 10(6):481-9. PubMed ID: 9826581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
    Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL.
    Ju SW; Ju SG; Wang FM; Gu ZJ; Qiu YH; Yu GH; Ma HB; Zhang XG
    Hybrid Hybridomics; 2003 Oct; 22(5):333-8. PubMed ID: 14678652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.
    Pulle G; Vidric M; Watts TH
    J Immunol; 2006 Mar; 176(5):2739-48. PubMed ID: 16493029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
    Sica G; Chen L
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):275-9. PubMed ID: 10604232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy targeting 4-1BB and its ligand.
    Vinay DS; Kwon BS
    Int J Hematol; 2006 Jan; 83(1):23-8. PubMed ID: 16443548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.
    Wilcox RA; Flies DB; Zhu G; Johnson AJ; Tamada K; Chapoval AI; Strome SE; Pease LR; Chen L
    J Clin Invest; 2002 Mar; 109(5):651-9. PubMed ID: 11877473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The therapeutic potential of 4-1BB (CD137) in cancer.
    Nam KO; Kang WJ; Kwon BS; Kim SJ; Lee HW
    Curr Cancer Drug Targets; 2005 Aug; 5(5):357-63. PubMed ID: 16101383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation: contribution of 4-1BB during inflammatory responses.
    Takahashi C; Mittler RS; Vella AT
    Immunol Lett; 2001 Apr; 76(3):183-91. PubMed ID: 11306146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.